Literature DB >> 23036602

Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis.

Hsu-Huan Chou1, Chia-Jung Kuo, Jun-Te Hsu, Tsung-Hsing Chen, Chun-Jun Lin, Jeng-Hwei Tseng, Ta-Sen Yeh, Tsann-Long Hwang, Yi-Yin Jan.   

Abstract

BACKGROUND: This study aimed to reveal the predictors for the recurrence pattern of gastric cancer (GC) and analyze the prognostic factors in node-negative advanced (T2 to T4) GC after curative resection.
METHODS: Between 1994 and 2006, 448 patients with node-negative advanced GC undergoing radical resection were enrolled in this study. Clinicopathologic factors affecting the recurrence pattern and prognosis for GC were analyzed.
RESULTS: Location, size, tumor invasion depth, and perineural invasion were associated with tumor recurrence and outcome. T4 status was a predictor for locoregional recurrence and peritoneal seeding, and a large tumor size and the presence of perineural invasion predicted hematogenous spread. Patients with only locoregional recurrence had better survival than those with peritoneal seeding or hematogenous spread.
CONCLUSIONS: In node-negative advanced GC, the prognostic factor differed significantly between locoregional recurrence/peritoneal seeding and hematogenous metastasis. Survival rates were higher in patients with locoregional recurrence alone than in patients with other recurrence patterns. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036602     DOI: 10.1016/j.amjsurg.2012.04.014

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

1.  Survival impact of the number of lymph node dissection on stage I-III node-negative gastric cancer.

Authors:  Jun-Te Hsu; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

2.  Survival in lymph node-negative gastric cancer: the Western experience.

Authors:  Linda X Jin; Ryan C Fields
Journal:  Transl Gastroenterol Hepatol       Date:  2016-07-29

3.  Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?

Authors:  Jun-Te Hsu; Puo-Hsien Le; Chia-Jung Kuo; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-07

4.  Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.

Authors:  Theresa L A Jeuck; Christian Wittekind
Journal:  Gastric Cancer       Date:  2014-02-19       Impact factor: 7.370

5.  Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.

Authors:  Liang Cao; Luke V Selby; Xiang Hu; Yi Zhang; Yelena Y Janjigian; Laura Tang; Daniel G Coit; Murray F Brennan; Vivian E Strong
Journal:  J Surg Oncol       Date:  2016-04-04       Impact factor: 3.454

6.  Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.

Authors:  Mesfin Esayas Lelisho; Geremew Muleta Akessa; Demeke Kifle Demissie; Samuel Fikadu Yermosa; Solomon Abebaw Andargie; Seid Ali Tareke; Digvijay Pandey
Journal:  J Gastrointest Cancer       Date:  2022-01-22

7.  Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer.

Authors:  Yongmei Yang; Lutao Du; Xiaoyun Yang; Ailin Qu; Xin Zhang; Chengjun Zhou; Chuanxin Wang
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 8.  Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors.

Authors:  Yanming Zhou; Feng Yu; Lupeng Wu; Feng Ye; Leilei Zhang; Yumin Li
Journal:  Med Sci Monit       Date:  2015-07-02

9.  Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.

Authors:  Jing-lei Qu; Xiu-juan Qu; Zhi Li; Jing-dong Zhang; Jing Liu; Yue-e Teng; Bo Jin; Ming-fang Zhao; Ping Yu; Jing Shi; Ling-Yu Fu; Zhen-ning Wang; Yun-peng Liu
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

10.  Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.

Authors:  Masaya Nakauchi; Elvira Vos; Laura H Tang; Mithat Gonen; Yelena Y Janjigian; Geoffrey Y Ku; David H Ilson; Steven B Maron; Sam S Yoon; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  Ann Surg Oncol       Date:  2021-02-10       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.